• 1. School of Nursing, Lanzhou University, Lanzhou 730000, P. R. China;
  • 2. Department of General Surgery, the First Hospital of Lanzhou University, Lanzhou 730000, P. R. China;
  • 3. Blood Purification Center, the First Hospital of Lanzhou University, Lanzhou 730000, P. R. China;
YANG Liping, Email: ylp0703@163.com
Export PDF Favorites Scan Get Citation

Objective To systematically review the efficacy of patient decision aids (PDA) in the selection of treatment modalities for end-stage renal diseases. Methods The PubMed, Web of Science, Embase, Cochrane Library, CBM, CNKI and VIP databases were electronically searched to collect randomized controlled trials (RCTs) related to the objectives from inception to March 2023. Two reviewers independently screened literature, extracted data and assessed the risk of bias of the included studies. Quantitative and qualitative analysis was then performed. Results A total of 8 RCTs involving 1 544 patients were included. The systematic review results showed that PDA could improve patient knowledge, reduce patient decision-making conflict, and change patient decision-making discussion rate. Conclusion Current evidence shows that patients with end-stage renal diseases can benefit from PDA to improve their decision-making knowledge and reduce conflicts in their decisions, but its impact on the decision-making outcome index is limited.

Citation: YAO Wufeng, YANG Liping, QIN Zilan, LI Kan, CHEN Hongzhuo, CHEN Jie, LIU Tianxi. Efficacy of PDA in the selection of treatment modalities for patients with end-stage renal disease: a systematic review. Chinese Journal of Evidence-Based Medicine, 2024, 24(1): 56-60. doi: 10.7507/1672-2531.202307020 Copy

  • Previous Article

    Risk prediction models for readmission within 30 days after discharge in patients with chronic obstructive pulmonary disease: a systematic review
  • Next Article

    Clinical applicability of guidelines evaluation index system: a systematic review